K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · ABT
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-27 | ABT | ABBOTT LABORATORIES | PHRONESISDC, LLC | $0 | Issues related to commercial litigation; Issues related to pension matters. Issues related to commercial litigation; Issues related to pension matters. Issues related to commercial litigation; Issues related to pension matters. Issues related to commercial litigation; Issues related to pension matters. |
| 2026-04-20 | ABT | ABBOTT LABORATORIES | ABBOTT LABORATORIES | $1.4M | Proposals to reform domestic and international tax structures. Proposals related to third party litigation reform. S. 3387 - Ensuring Safe and Toxic-Free Foods Act of 2023. H.R. 9817 Toxic Free Food Act of 2024. H.R. 4958 The Grocery Reform and Safety (GRAS) Act. Proposals related to heavy metals in food. Proposals related to pension premiums and employee benefits. Proposals related to the use of the Uniform Commercial Code (UCC). Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations. H.R. 7118 The Genomic Answers for Children's Health Act. Proposals related to the advancement, testing and detection of Traumatic Brain Injury (TBI). Proposals related to Department of Defense coverage of continuous glucose monitors. Proposals related to the coverage of continuous glucose monitors in TRICARE. Proposals to support updates to the Veteran colorectal cancer screening directive. S. 2761/H.R. 5269 The Reforming an |
| 2026-04-20 | ABT | ABBOTT LABORATORIES | AKIN GUMP STRAUSS HAUER & FELD | $60K | Issues related to Japan operations. |
| 2026-04-20 | ABT | ABBOTT LABORATORIES | W STRATEGIES, LLC | $50K | Issues related to infant formula access. H.R.2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. |
| 2026-04-20 | ABT | ABBOTT LABORATORIES | FEDERAL HEALTH POLICY STRATEGIES | $0 | |
| 2026-04-20 | ABT | ABBOTT LABORATORIES | MAYER BROWN LLP | $0 | Issues related to OECD tax negotiations. |
| 2026-04-20 | ABT | ABBOTT LABORATORIES | ABBOTT LABORATORIES | $0 | |
| 2026-04-18 | ABT | ABBOTT LABORATORIES | TIBER CREEK GROUP | $50K | Issues related to global health policy and funding; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75). Issues related to global health policy and funding. |
| 2026-04-17 | ABT | ABBOTT LABORATORIES | MARSHALL & POPP, LLC | $60K | Issues related to infant formula, including H.R. 2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula. Proposals related to Medicare coverage of continuous glucose monitors. |
| 2026-04-17 | ABT | ABBOTT LABORATORIES | S-3 GROUP | $60K | Issues related to infant formula Equitable Access to Community Pharmacist Services Act Equitable Access to Community Pharmacist Services Act Proposals to reform domestic and international tax structures |
| 2026-04-09 | ABT | ABBOTT LABORATORIES | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to the supply of infant formula and nutrition. Issues related to corporate taxation. Issues related to medical device reimbursement. Issues related to diagnostic testing. |
| 2026-01-20 | ABT | ABBOTT LABORATORIES | ABBOTT LABORATORIES | $900K | S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors. Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance. H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula. Proposals regarding the implementation and modernization of the WIC Program. Proposals to reform domestic and international tax structures. S. 2426 Equitable Community Access to Pharmacist Services Act. Proposals related to the advancement, testing and detection of Traumatic Brain Injury (TBI). Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR). |
| 2026-01-20 | ABT | ABBOTT LABORATORIES | S-3 GROUP | $60K | Issues related to infant formula Equitable Access to Community Pharmacist Services Act Equitable Access to Community Pharmacist Services Act Proposals to reform domestic and international tax structures |
| 2026-01-20 | ABT | ABBOTT LABORATORIES | AKIN GUMP STRAUSS HAUER & FELD | $60K | |
| 2026-01-20 | ABT | ABBOTT LABORATORIES | W STRATEGIES, LLC | $50K | Issues related to infant formula access. H.R.2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. |
| 2026-01-20 | ABT | ABBOTT LABORATORIES | FEDERAL HEALTH POLICY STRATEGIES | $0 | |
| 2026-01-20 | ABT | ABBOTT LABORATORIES | MAYER BROWN LLP | $0 | OECD tax negotiations. |
| 2026-01-17 | ABT | ABBOTT LABORATORIES | TIBER CREEK GROUP | $50K | Issues related to global health policy and funding. Issues related to global health policy and funding; H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026. |
| 2026-01-16 | ABT | ABBOTT LABORATORIES | MARSHALL & POPP, LLC | $60K | Issues related to infant formula, including: H.R.4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; H.R. 2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes; and H.R. 5371 - Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026. Proposals related to Medicare coverage of continuous glucose monitors. |
| 2026-01-13 | ABT | ABBOTT LABORATORIES | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to the supply of infant formula and nutrition. Issues related to corporate taxation. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to medical device reimbursement. |
| 2025-10-20 | ABT | ABBOTT LABORATORIES | ABBOTT LABORATORIES | $1.1M | Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations. Proposals related to third party litigation reform. Proposals to reform domestic and international tax structures. S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. S. 2922/H.R. 7164 Advancing Research for Chronic Pain Act of 2024. Proposals related to digital health technologies and innovations. Proposals to advance policies related to effective pain management. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR). S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors. Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance. H.R. 2300 To ensure national uni |
| 2025-10-20 | ABT | ABBOTT LABORATORIES | AKIN GUMP STRAUSS HAUER & FELD | $60K | |
| 2025-10-20 | ABT | ABBOTT LABORATORIES | S-3 GROUP | $60K | Equitable Access to Community Pharmacist Services Act Equitable Access to Community Pharmacist Services Act Proposals to reform domestic and international tax structures Issues related to infant formula |
| 2025-10-20 | ABT | ABBOTT LABORATORIES | MARSHALL & POPP, LLC | $60K | Issues related to infant formula, including: H.R.4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. |
| 2025-10-20 | ABT | ABBOTT LABORATORIES | FEDERAL HEALTH POLICY STRATEGIES | $0 | |
| 2025-10-19 | ABT | ABBOTT LABORATORIES | TIBER CREEK GROUP | $50K | Issues related to global health policy and funding. Issues related to global health policy and funding; H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026. |
| 2025-10-15 | ABT | ABBOTT LABORATORIES | W STRATEGIES, LLC | $50K | Issues related to infant formula access. H.R.2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. |
| 2025-10-15 | ABT | ABBOTT LABORATORIES | MAYER BROWN LLP | $0 | |
| 2025-10-09 | ABT | ABBOTT LABORATORIES | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to the supply of infant formula and nutrition. Issues related to corporate taxation. Issues related to cardiovascular health. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act. |
| 2025-07-21 | ABT | ABBOTT LABORATORIES | ABBOTT LABORATORIES | $814K | S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. Proposals related to medical device cybersecurity. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR). Proposals related to Medicare coverage of continuous glucose monitors. Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations. Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance. Proposals related to preserving critical medical supply chains. H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula. Proposals to reform domestic and international tax structures. S. 3387 - Ensuring Safe and Toxic-Free Foods Act of 2023. H.R. 9817 Toxic Free Food Act of 2024. |
| 2025-07-21 | ABT | ABBOTT LABORATORIES | MARSHALL & POPP, LLC | $60K | H.R.4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 - Issues related to infant formula. |
| 2025-07-21 | ABT | ABBOTT LABORATORIES | AKIN GUMP STRAUSS HAUER & FELD | $60K | Issues related to U.S.-U.K. trade relations and supply chains. |
| 2025-07-21 | ABT | ABBOTT LABORATORIES | FEDERAL HEALTH POLICY STRATEGIES | $0 | |
| 2025-07-20 | ABT | ABBOTT LABORATORIES | TIBER CREEK GROUP | $50K | Issues related to global health policy and funding. Issues related to global health policy and funding. |
| 2025-07-18 | ABT | ABBOTT LABORATORIES | S-3 GROUP | $60K | Issues related to infant formula Equitable Access to Community Pharmacist Services Act Equitable Access to Community Pharmacist Services Act Proposals to reform domestic and international tax structures |
| 2025-07-18 | ABT | ABBOTT LABORATORIES | W STRATEGIES, LLC | $50K | Issues related to infant formula access. H.R.2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. |
| 2025-07-18 | ABT | ABBOTT LABORATORIES | MAYER BROWN LLP | $10K | Issues related to OECD tax negotiations. |
| 2025-07-15 | ABT | ABBOTT LABORATORIES | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to the supply of infant formula and nutrition. Issues related to corporate taxation. Issues related to cardiovascular health. |
| 2025-04-21 | ABT | ABBOTT LABORATORIES | ABBOTT LABORATORIES | $1.8M | S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. Proposals related to telehealth implementation and remote monitoring. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR). S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors. Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations. Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance. H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula. Proposals to reform domestic and international tax structures. S. 3387 - Ensuring Safe and Toxic |
| 2025-04-21 | ABT | ABBOTT LABORATORIES | MARSHALL & POPP, LLC | $60K | Issues related to infant formula. |
| 2025-04-21 | ABT | ABBOTT LABORATORIES | AKIN GUMP STRAUSS HAUER & FELD | $60K | |
| 2025-04-21 | ABT | ABBOTT LABORATORIES | S-3 GROUP | $60K | Issues related to infant formula Equitable Access to Community Pharmacist Services Act Equitable Access to Community Pharmacist Services Act Proposals to reform domestic and international tax structures |
| 2025-04-20 | ABT | ABBOTT LABORATORIES | TIBER CREEK GROUP | $50K | Issues related to global health policy and funding. Issues related to global health policy and funding. |
| 2025-04-18 | ABT | ABBOTT LABORATORIES | W STRATEGIES, LLC | $50K | Issues related to infant formula access. |
| 2025-04-18 | ABT | ABBOTT LABORATORIES | FEDERAL HEALTH POLICY STRATEGIES | $0 | |
| 2025-04-17 | ABT | ABBOTT LABORATORIES | MAYER BROWN LLP | $0 | Issues related to OECD tax negotiations. |
| 2025-04-14 | ABT | ABBOTT LABORATORIES | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to the supply of Infant Formula. |
| 2025-04-10 | ABT | ABBOTT LABORATORIES | BGR GOVERNMENT AFFAIRS | $10K | Global health issues |
| 2025-03-24 | ABT | ABBOTT LABORATORIES | MARSHALL & POPP, LLC | $0 | Issues related to infant formula. Issues related to infant formula. Issues related to infant formula. Issues related to infant formula. Issues related to infant formula. |
| 2025-03-10 | ABT | ABBOTT LABORATORIES | S-3 GROUP | $0 | Equitable Access to Community Pharmacist Services Act; proposals to reform domestic and international tax structures; infant formula Equitable Access to Community Pharmacist Services Act; proposals to reform domestic and international tax structures; infant formula Equitable Access to Community Pharmacist Services Act; proposals to reform domestic and international tax structures; infant formula Equitable Access to Community Pharmacist Services Act; proposals to reform domestic and international tax structures; infant formula |
| 2025-02-16 | ABT | ABBOTT LABORATORIES | TIBER CREEK GROUP | $0 | Global health policy and funding. Global health policy and funding. Global health policy and funding. |
| 2025-01-21 | ABT | ABBOTT LABORATORIES | ABBOTT LABORATORIES | $1.1M | S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. Proposals related to medical device cybersecurity. Proposals related to heart valve repair technologies. Proposals related to sterilization of medical devices. Proposals related to testing for malaria. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR). S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Proposals related to Medicare coverage of continuous glucose monitors. Proposals to ensure Medicare coverage for emerging medical device technology. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance. Proposals regarding infant and child nutrition. Proposals related to tariffs on products imported into the United Sta |
| 2025-01-21 | ABT | ABBOTT LABORATORIES | AKIN GUMP STRAUSS HAUER & FELD | $60K | Issues related to infant formula liability reform. Issues related to international taxation. |
| 2025-01-21 | ABT | ABBOTT LABORATORIES | THEGROUP DC, LLC | $60K | Monitored proposals dealing with the corporate tax rate and international tax regimes. S. 2477, Equitable Community Access to Pharmacist Services Act, all provisions Issues related to infant formula |
| 2025-01-21 | ABT | ABBOTT LABORATORIES | W STRATEGIES, LLC | $50K | H.R.4128: VALID Act of 2021. H.R.7213 - Equitable Community Access to Pharmacist Services Act. Issues related to infant formula access. |
| 2025-01-21 | ABT | ABBOTT LABORATORIES | MAYER BROWN LLP | $0 | Issues related to OECD tax negotiations. |
| 2025-01-21 | ABT | ABBOTT LABORATORIES | FEDERAL HEALTH POLICY STRATEGIES | $0 | |
| 2025-01-20 | ABT | ABBOTT LABORATORIES | ABBOTT LABORATORIES | $1.1M | S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Proposals related to Medicare coverage of continuous glucose monitors. Proposals to ensure Medicare coverage for emerging medical device technology. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance. Proposals regarding infant and child nutrition. Proposals related to tariffs on products imported into the United States. Proposals related to access to infant formula. Public Law 115-97 The Tax Cuts and Jobs Act. Public Law 117-169 Inflation Reduction Act of 2022. Proposals to reform domestic and international tax structures. S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. Proposals related to medical device cybersecurity. Proposals rel |
| 2025-01-20 | ABT | ABBOTT LABORATORIES | BGR GOVERNMENT AFFAIRS | $30K | Global health issues |